Sodium picosulfate is converted by intestinal bacteria into the active metabolite BHPM.The terminal half-life of sodium picosulfate is 7.4 hours.Approximately 0.19% of the absorbed sodium picosulfate dose is excreted unchanged in the urine.Plasma concentrations of free BHPM are extremely low.Urinary analysis shows that most excreted BHPM is in the glucuronide-conjugated form.
禁忌症
Severe renal impairment (creatinine clearance < 30 mL/min),gastrointestinal obstruction or ileus,bowel perforation,toxic colitis or toxic megacolon,gastric retention,hypersensitivity to any component of PMC
懷孕分類
B
哺乳分類
Unknown
副作用
Nausea, headache, vomiting, electrolyte imbalance
劑量和給藥方法
Before each use, dissolve one sachet of PMC powder in approximately 150 mL of room-temperature cold water and stir for at least 5 minutes.As the powder dissolves, the temperature of the solution may increase slightly.Take the first sachet on the evening before the colonoscopy (e.g., between 5 PM and 9 PM).Within 5 hours after administration, consume at least five 250 mL servings of clear liquids.Prepare and take the second sachet 5 hours before the colonoscopy the next day.Within 2 hours after administration, consume at least three 250 mL servings of clear liquids.If severe bloating, abdominal distension, or abdominal pain occurs after the first dose, delay the second dose until symptoms resolve.
小兒調整劑量
Unknown
腎功能調整劑量
Contraindicated in severe renal impairment (creatinine clearance < 30 mL/min)
肝功能調整劑量
No data available
安定性
Store below 25°C
藥袋資訊
臨床用途
緩瀉劑
主要副作用
噁心、嘔吐、頭痛、腹瀉、腹痛
泡製方法
儲存方式
請置於 15-30℃ 乾燥處儲存。
注意事項
其他說明
藥局 P4 | 小庫 I | 藥庫 口J22 | <一盒2包,以盒給藥,本品離院後無法辦理退藥(費)>